Equities research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a report released on Friday. The firm set a “hold” rating on the ...

Here are three significant recalls reported to the FDA since early December: ...

The European Medicines Agency (EMA) has approved Roche’s Vabysmo (faricimab) in single-dose prefilled syringe form for three ...

The notice from the U.S. Trade Representative’s office said tariffs on Chinese-made solar wafers and polysilicon will rise to ...

Real-time index price for Nasdaq US Sm Cap Consumer Electronics Index (NQCE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Taiwan says China sending largest naval fleet in years to region Request To Download Sample of This Strategic Report @ Highlighted with 73 tables and 57 figures, this 150-page report ?Asia Pacific ...

Request To Download Sample of This Strategic Report @ Highlighted with 76 tables and 58 figures, this 150-page report ?Europe Disposable Medical Supplies Market 2022-2030. Profound analysis and ...

J.P. Morgan analyst David Adlington maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of €111.40.

CVS Health has struggled post-pandemic due to rising costs, regulatory scrutiny, and poor management decisions, leading to ...

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

When Agnes Kativhu could not get treatment for breast cancer from Harare's main public hospital, she checked in to one of the ...

More than 40 percent of Americans are now classified as obese while 75 percent of adults are either overweight or obese. A new group of drugs called GLP-1 receptor agonists have come on the scene to ...